Policy Briefings

Agilent to Acquire Biocare Medical in $950 Million All-Cash Deal

GelMEDIX Partners with Catalent for iPSC Cell Therapy Development and Manufacturing

Chiesi Expands Partnership with Bespak to Increase pMDI Manufacturing Capacity

Ardena Enables PharmaResearch’s PRD-101 to Enter Phase 1

Cellistic Appoints Jason Conner as Chief Executive Officer

Polyrizon Completes GMP Batch Production with Eurofins CDMO

mAbxience Selects Genedata Bioprocess Platform to Automate CDMO Bioprocess Workflows

Andelyn Biosciences Launches The Andelyn Foundation to Support Rare Disease Families

Samsung Biologics Partners with Eli Lilly to Launch Lilly Gateway Labs Site in Korea

Kenox Pharmaceuticals Expands OINDP Testing Capabilities

Kenox Pharmaceuticals Announces Clinical Manufacturing Readiness for OINDP Programs

AsymBio Activates Fengxian Commercial Manufacturing Site

SimAbs Raises €5 Million Series A to Expand Continuous Antibody Manufacturing Platform

Neuland Laboratories Plans Commercial Peptide Manufacturing Facility Opening in Summer 2026

Lonza Extends Manufacturing Agreement With Genetix for ZYNTEGLO™ Gene Therapy

Naobios Partners With SGS to Manufacture RSV Challenge Agent for CHIM Studies

The BMC: A Strategic Partner for the Biotechnology and Biopharmaceutical Industry [CDMO Spotlight]

Lonza Selects Hyderabad for New Global Capability Centre